Clinical characteristics of older adults with hypertension and unrecognized cognitive impairment
- PMID: 35210565
- DOI: 10.1038/s41440-022-00861-z
Clinical characteristics of older adults with hypertension and unrecognized cognitive impairment
Abstract
To treat older patients with hypertension, it is important to detect cognitive impairment at an early stage because of its potential influence on treatment efficacy and functional prognosis. In this study, we aimed to identify the incidence and determinants of cognitive impairment in hypertensive patients aged 65 years and above who visited our outpatient clinic and were not previously diagnosed with cognitive impairment. Among 312 patients with hypertension, we found that 35% (n = 109) and 7.7% (n = 24) had cognitive impairment and dementia, respectively, as defined by the Mini-Mental State Examination (≤27 or ≤23, respectively). Patients with cognitive impairment were older, had lower levels of education, and had lower instrumental activities of daily living (IADL) scores than those without cognitive impairment. Multiple regression analysis revealed that age and IADL were associated with cognitive impairment in patients with hypertension. Regarding the treatment of hypertension, the office and home blood pressure levels, number of antihypertensive medications prescribed, and proportion of the use of each antihypertensive drug was equivalent between patients with and without cognitive impairment. Finally, patients with unrecognized cognitive impairment showed distinct clinical characteristics, including high antihypertensive medication burden and preserved IADL, when compared to hypertensive patients in the different cohorts of definitive mild cognitive impairment of a similar age. These findings suggest that older hypertensive patients are at a high risk of masked cognitive decline, even if they are functionally independent.
Keywords: Cognitive impairment; Hypertension; Mild cognitive impairment; Outpatient clinic.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Comment in
-
Is unrecognized cognitive impairment in hypertension unmasked by diabetes mellitus?Hypertens Res. 2022 Jun;45(6):1082-1084. doi: 10.1038/s41440-022-00906-3. Epub 2022 Apr 8. Hypertens Res. 2022. PMID: 35396466 No abstract available.
Similar articles
-
Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia.Sci Rep. 2018 Aug 3;8(1):11688. doi: 10.1038/s41598-018-29974-7. Sci Rep. 2018. PMID: 30076332 Free PMC article.
-
How do impairments in cognitive functions affect activities of daily living functions in older adults?PLoS One. 2019 Jun 7;14(6):e0218112. doi: 10.1371/journal.pone.0218112. eCollection 2019. PLoS One. 2019. PMID: 31173607 Free PMC article.
-
Effects of tai chi on cognition and instrumental activities of daily living in community dwelling older people with mild cognitive impairment.BMC Geriatr. 2018 Feb 2;18(1):37. doi: 10.1186/s12877-018-0720-8. BMC Geriatr. 2018. PMID: 29394884 Free PMC article. Clinical Trial.
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. PMID: 24354019 Free Books & Documents. Review.
-
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004034. doi: 10.1002/14651858.CD004034.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2021 May 24;5:CD004034. doi: 10.1002/14651858.CD004034.pub4. PMID: 19821318 Free PMC article. Updated. Review.
Cited by
-
Prevalence and risk factors of cognitive impairment in Chinese patients with hypertension: a systematic review and meta-analysis.Front Neurol. 2024 Feb 13;14:1271437. doi: 10.3389/fneur.2023.1271437. eCollection 2023. Front Neurol. 2024. PMID: 38414728 Free PMC article.
-
2023 update and perspectives.Hypertens Res. 2024 Jan;47(1):6-32. doi: 10.1038/s41440-023-01398-5. Epub 2023 Sep 15. Hypertens Res. 2024. PMID: 37710033 Review.
-
A risk prediction model based on machine learning for early cognitive impairment in hypertension: Development and validation study.Front Public Health. 2023 Mar 9;11:1143019. doi: 10.3389/fpubh.2023.1143019. eCollection 2023. Front Public Health. 2023. PMID: 36969637 Free PMC article.
-
Association of Type D personality and mild cognitive impairment in patients with hypertension.Front Psychol. 2022 Nov 16;13:974430. doi: 10.3389/fpsyg.2022.974430. eCollection 2022. Front Psychol. 2022. PMID: 36467148 Free PMC article.
References
-
- Hudani ZK, Rojas-Fernandez CH. A scoping review on medication adherence in older patients with cognitive impairment or dementia. Res Soc Adm Pharm. 2016;12:815–29. - DOI
-
- Yamazaki Y, Miwa T, Sakurai H, Hanyu H, Iwamoto T, Odawara M. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011;58:109–15. - DOI
-
- Murata Y, Kadoya Y, Yamada S, Sanke T. Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. Diabetol Int. 2017;8:193–8. - DOI
-
- Kume Y, Takahashi T, Itakura Y, Lee S, Makizako H, Ono T, et al. Characteristics of Mild Cognitive Impairment in Northern Japanese Community-Dwellers from the ORANGE Registry. J Clin Med. 2019;8:1937.
-
- Saji N, Sakurai T, Suzuki K, Mizusawa H, Toba K, investigators O. ORANGE’s challenge: developing wide-ranging dementia research in Japan. Lancet Neurol. 2016;15:661–2. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical